← Back to Search

Behavioral Intervention

Pivotal Response Training for Autism (PRT-C Trial)

N/A
Recruiting
Led By Antonio Y. Hardan, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stable treatment (e.g., applied behavior analysis (ABA), speech therapy, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation
Boys and girls between 2 years and 3 years and 11 months
Must not have
Presence of active medical problem (e.g., unstable seizure disorder or heart disease)
More than 15 hours per week of in-home applied behavior analysis (ABA).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial will study if a treatment called "pivotal response training" can help improve social communication skills in children with autism spectrum disorder.

Who is the study for?
This trial is for preschoolers aged 2 to almost 4 years with Autism Spectrum Disorder (ASD), who have a developmental delay and are English-speaking. They should be on stable treatment without changes expected during the study, and must not have had an adequate trial of Pivotal Response Treatment before.
What is being tested?
The effectiveness of intensive center-based Pivotal Response Training (PRT-C) is being tested to improve social communication in children with ASD. The study will observe how this specific setting influences the progress made by participants.
What are the potential side effects?
Since PRT-C is a behavioral intervention rather than a medication, it does not have traditional side effects. However, there may be variations in behavior or emotional responses as children adjust to the therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My current treatment for behavior or speech issues has been stable for at least 1 month.
Select...
My child is between 2 and 3 years and 11 months old.
Select...
I have been diagnosed with Autism Spectrum Disorder by a specialist.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a serious health issue like uncontrolled seizures or heart disease.
Select...
I receive over 15 hours of ABA therapy at home weekly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive Center-Based Pivotal Response Treatment (PRT-C)Experimental Treatment1 Intervention
Intensive Center-Based Pivotal Response Treatment (PRT-C) will consist of a combination of one weekly 60-minute individual parent training session and 12 weekly hours ( 3 hours per day for 4 days per week) with the child in center-based therapy environment for a total of 13 weekly treatment hours.
Group II: Delayed Treatment Group (DTG)Active Control1 Intervention
Delayed Treatment Group will consist of treatment as usual. At the end of controlled phase, participants in the DTG will be offered PRT-C in a preschool setting in an open-label fashion with a design similar to the double-blind phase.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,448 Previous Clinical Trials
17,492,350 Total Patients Enrolled
35 Trials studying Autism Spectrum Disorder
4,082 Patients Enrolled for Autism Spectrum Disorder
John & Marcia Goldman FoundationUNKNOWN
1 Previous Clinical Trials
75 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
75 Patients Enrolled for Autism Spectrum Disorder
Antonio Y. Hardan, MDPrincipal InvestigatorStanford University
9 Previous Clinical Trials
437 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
389 Patients Enrolled for Autism Spectrum Disorder

Media Library

Pivotal Response Treatment (PRT-C) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03778827 — N/A
Autism Spectrum Disorder Research Study Groups: Intensive Center-Based Pivotal Response Treatment (PRT-C), Delayed Treatment Group (DTG)
Autism Spectrum Disorder Clinical Trial 2023: Pivotal Response Treatment (PRT-C) Highlights & Side Effects. Trial Name: NCT03778827 — N/A
Pivotal Response Treatment (PRT-C) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03778827 — N/A
~8 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top